Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer

CRC screening—cost effectiveness of fecal immunochemical tests

Nature Reviews Gastroenterology & Hepatology volume 8, pages 663–664 (2011)Cite this article

Subjects

For colorectal cancer screening, the issue is no longer whether the fecal immunochemical test (FIT) is preferable to the guaiac fecal occult blood test, but how best to use the FIT. Using the OC-Sensor™ FIT with a hemoglobin cut-off level of 50 ng/ml could offer the best cost-effectiveness ratio compared with nonscreening settings.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lansdorp-Vogelaar, I., Knudsen, A. B. & Brenner, H. Cost-effectiveness of colorectal cancer screening. Epidemiol. Rev. 33, 88–100 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Chen, L. S., Liao, C. S., Chang, S. H., Lai, H. C. & Chen, T. H. Cost-effectiveness analysis for determining optimal cut-off of immunochemical fecal occult blood test for population-based colorectal cancer screening (KCIS 16). J. Med. Screen. 14, 191–199 (2007).

    Article  PubMed  Google Scholar 

  3. Parekh, M., Fendrick, A. M. & Ladabaum, U. As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia. Aliment. Pharmacol. Ther. 27, 697–712 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wilschut, J. A. et al. Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology doi:10.1053/j.gastro.2011.07.020.

    Article  Google Scholar 

  5. Loeve, F., Boer, R., van Oortmarssen, G. J., van Ballegooijen, M. & Habbema, J. D. The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput. Biomed. Res. 32, 13–33 (1999).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. INSERM Université de Caen Basse-Normandie, Esplanade de la Paix, BP 5186, Caen Cedex, 14032, France

    Celia Berchi & Guy Launoy

Authors
  1. Celia Berchi
    View author publications

    Search author on:PubMed Google Scholar

  2. Guy Launoy
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Guy Launoy.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berchi, C., Launoy, G. CRC screening—cost effectiveness of fecal immunochemical tests. Nat Rev Gastroenterol Hepatol 8, 663–664 (2011). https://doi.org/10.1038/nrgastro.2011.198

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrgastro.2011.198

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer